US equities |
NVDA $238.90 ▲+2.12% SPCX $171.09 ▲+7.63% MU $1,063.96 ▼-1.02% TSLA $378.73 ▲+2.20% WBD $30.95 ▲+0.03% MSFT $525.18 ▲+1.48% AAPL $332.89 ▼-0.24% META $741.90 ▲+1.90%
FinancialContent

Latest News about Jason Carroll

Recent news which mentions Jason Carroll

Tryptamine Therapeutics Advances Psilocin-Based IV Infusion To Phase 2 Clinical Trials
Tickers NEWS TYPTF
Tags Tryptamine Therapeutics Jason Carroll TYPTF
From Benzinga
Tryp Therapeutics Set To Finalize Merger With Exopharm, Announces Trading Halt Ahead Of ASX Listing
Tickers TRYPF
Tags Tryptamine Therapeutics Jason Carroll OTCQB Venture Market
From Benzinga